Especially the microglial-specific inhibition of TAK1 seems to dampen post-ischemic neuroinflammation sustainably and improve neurological outcome after stroke indicating that microglia exert detrimental pro-inflammatory and pro-apoptotic effects in the early phase after ischemia. The gene discussed is MAP3K7; the disease is stroke disorder.